Effect of Green Tea on Treatment of Lupus
Palabras clave
Abstracto
Descripción
noting
fechas
Verificado por última vez: | 04/30/2016 |
Primero enviado: | 05/27/2016 |
Inscripción estimada enviada: | 08/17/2016 |
Publicado por primera vez: | 08/22/2016 |
Última actualización enviada: | 08/17/2016 |
Última actualización publicada: | 08/22/2016 |
Fecha de inicio real del estudio: | 08/31/2015 |
Fecha estimada de finalización primaria: | 02/29/2016 |
Fecha estimada de finalización del estudio: | 02/29/2016 |
Condición o enfermedad
Intervención / tratamiento
Dietary Supplement: green tea extract
Dietary Supplement: Placebo
Fase
Grupos de brazos
Brazo | Intervención / tratamiento |
---|---|
Active Comparator: green tea extract Patients were given daily dose of 1000mg aqueous green tea extract (of 6 grams of dried green tea leaf) in the form of 2 capsules (500 mg) for three months. | Dietary Supplement: green tea extract Patients are given daily dose of 1000mg aqueous green tea extract (of 6 grams of dried green tea leaf) in the form of 2 capsules( 500 mg) for three months. |
Placebo Comparator: Placebo Patients in placebo group received daily dose of 1000 mg cellulose in the form of 2 capsules (500 mg) for three months | Dietary Supplement: Placebo Patients in placebo group receive daily dose of 1000 mg cellulose in the form of 2 capsules (500 mg) for three months |
Criterio de elegibilidad
Edades elegibles para estudiar | 15 Years A 15 Years |
Sexos elegibles para estudiar | Female |
Acepta voluntarios saludables | si |
Criterios | Inclusion Criteria: The patients older than 15 years,diagnosed with systemic lupus erythematous (SLE) according to ACR(American College of Rheumatology) criteria. Exclusion Criteria: - Patients with other autoimmune diseases (diabetes, ...) - Cardiovascular disease - Patients with infectious or liver disease; - severe infection - Pregnancy - Breastfeeding - Smoking - Alcohol consumption - Use of any dietary supplements - Changing of medication during the study period |
Salir
Medidas de resultado primarias
1. systemic lupus erythematous Disease Activity [Three months after starting of intervention]
Medidas de resultado secundarias
1. measurement of some proinflammatory and anthropometric markers [At baseline and after three months of intervention]
2. Health-Related Quality of Life [At baseline and after three months of intervention]
Otras medidas de resultado
1. Dietary intake [at baseline and after 3 month of intervention]
2. Weight [at baseline and after 3 month of intervention]
3. BMI [at baseline and after 3 month of intervention]